← All companies

RIGL

Rigel Pharmaceuticals, Inc.

RIGL Nasdaq Pharmaceutical Preparations EDGAR ↗

$37.43

+0.62 +1.68%

Key statistics

from XBRL data in SEC filings

Market cap

$693M

Revenue (TTM)

$300M

Net income (TTM)

$364M

EPS (TTM)

$19.29

P/E ratio

1.9

Dividend yield

—

Free cash flow

$75.2M

Cash

$24.4M

Total assets

$505M

Gross margin

20.3%

52-week range

$21.87 – $52.24

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Director or officer change Jul 1, 2026 8-K Completed an acquisition or disposition Jun 17, 2026 8-K Director or officer change; Shareholder vote results May 20, 2026 8-K Entered a material agreement May 12, 2026 8-K Results of operations (earnings release) May 5, 2026 10-Q Quarter ended 2026-03-31 May 5, 2026 8-K Terminated a material agreement Apr 21, 2026 8-K Results of operations (earnings release) Mar 3, 2026 10-K Fiscal year ended 2025-12-31 Mar 3, 2026 8-K Director or officer change Feb 3, 2026 8-K Results of operations (earnings release); Other events Jan 12, 2026 8-K Other events Dec 10, 2025 8-K Results of operations (earnings release) Nov 4, 2025 10-Q Quarter ended 2025-09-30 Nov 4, 2025 10-Q Quarter ended 2025-06-30 Aug 5, 2025 8-K Results of operations (earnings release) Aug 5, 2025 8-K Director or officer change; Shareholder vote results May 23, 2025 8-K Results of operations (earnings release) May 6, 2025 10-Q Quarter ended 2025-03-31 May 6, 2025 8-K Other events Mar 27, 2025 8-K Director or officer change Mar 10, 2025 8-K Results of operations (earnings release) Mar 4, 2025 10-K Fiscal year ended 2024-12-31 Mar 4, 2025 8-K Results of operations (earnings release); Other events Jan 13, 2025 8-K Other events Dec 9, 2024 8-K Results of operations (earnings release) Nov 7, 2024 10-Q Quarter ended 2024-09-30 Nov 7, 2024 8-K Director or officer change Sep 19, 2024 8-K Entered a material agreement Sep 3, 2024 8-K Results of operations (earnings release) Aug 6, 2024 10-Q Quarter ended 2024-06-30 Aug 6, 2024 8-K Modified rights of security holders; Amended charter or bylaws Jun 27, 2024 8-K Other events Jun 25, 2024 8-K Director or officer change; Shareholder vote results May 29, 2024 8-K Results of operations (earnings release) May 7, 2024 10-Q Quarter ended 2024-03-31 May 7, 2024 8-K Entered a material agreement Apr 12, 2024 8-K Results of operations (earnings release) Mar 5, 2024 10-K Fiscal year ended 2023-12-31 Mar 5, 2024 8-K Entered a material agreement; Completed an acquisition or disposition Feb 22, 2024